tenofovir has been researched along with Adult Fanconi Syndrome in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 35 (38.04) | 29.6817 |
2010's | 45 (48.91) | 24.3611 |
2020's | 12 (13.04) | 2.80 |
Authors | Studies |
---|---|
Drak, D; Gowers, A; Gracey, DM; Lin, J | 1 |
Karoney, MJ; Koech, MK; Njiru, EW; Owino Ong'or, WD | 1 |
Hemmingsson, P; Lodin, K; Rosenborg, S | 1 |
Gill, S; Kalinoski, T; Mehboob, G; Mpejane, O; Zilwa, N | 1 |
Geng, H; Heng, H; Li, J; Liang, J; Liu, X; Zang, X | 1 |
Behrendt, H; Bieda, A; Leśniak, K; Niemczyk, S | 1 |
Bani-Sadr, F; Berger, JL; Brunet, A; Favarel-Garrigues, M; Hentzien, M | 1 |
Álvarez, H; Llibre, JM | 1 |
Bahr, NC; Yarlagadda, SG | 2 |
Hooi, B; Leungsuwan, S; Myint, KS | 1 |
Bwakura-Dangarembizi, MF; Maponga, CC; Mashingaidze-Mano, R; Monera-Penduka, TG; Morse, GD; Mtisi, TJ; Mudzviti, T; Mujuru, HA | 1 |
Bloch, M; Gracey, DM; Heron, JE; Saunders, J; Vanguru, V | 1 |
Kumar, B; Prabhakar, R; Thangavelu, S | 1 |
Iatan, I; Lee, TC; McDonald, EG | 1 |
Karris, MY | 1 |
Chen, M; Chow, EP; Fairley, CK; Medland, NA; Read, TR; Walker, RG | 1 |
Cho, JH; Choi, SW; Chun, DI; Kwon, SH; Lee, HW; Nho, JH; Suh, YS; Won, SH | 1 |
Akunuri, S; Kallampallil, J; Leong, S; Maweni, R | 1 |
Chen, CL; Chen, NC; Chung, TL | 1 |
Hiraoka, A; Izumoto, H; Kitahata, S; Kondoh, K; Michitaka, K; Ninomiya, T; Tsubouchi, E; Ueki, H; Yamago, H | 1 |
Fujii, T; Kawasoe, K; Nitta, K; Ohta, A | 1 |
Colmenero, J; Forns, X; Gómez-Hernando, M; Llach, J | 1 |
Gracey, DM; McKenzie, P; Snelling, P; Strasser, SI | 1 |
Hsu, P; Lucey, JM; Ziegler, JB | 1 |
Amann, K; Bickel, M; Brodt, HR; Buettner, M; Geiger, H; Gute, P; Haberl, A; Jung, O; Khaykin, P; Lutz, T; Schmidt, K; Stephan, C | 1 |
Becker, C; Hamnvik, OP; Vaidya, A | 1 |
Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J | 1 |
Abraham, P; Isaac, B; Ramamoorthy, H | 1 |
Anderson, AM; Ebrahimi, R; Flaherty, JF; Fortin, C; Fralich, T; Graham, H; Gupta, SK; Kalayjian, RC; Rachlis, A; Scharen-Guivel, V; Wyatt, CM | 1 |
Holmes, DT; Jiang, SY; Kendler, DL; Saeedi, R | 1 |
Eliadi, I; Polyzos, A; Samarkos, M; Theofanis, V; Vlachogiannakos, J | 1 |
Brocchieri, A; Castelli, F; Colombo, M; Facchetti, F; Fugazza, A; Lampertico, P; Mangia, G; Spinetti, A; Viganò, M; Zaltron, S | 1 |
Bam, R; Cihlar, T; Dahlin, A; de la Cruz, M; Flaherty, J; Giacomini, KM; Gupta, SK; Ray, AS; Scharen-Guivel, V; Wittwer, M; Woo, JM | 1 |
Hwang, HS; Park, CW; Song, MJ | 1 |
Arends, JE; Harkisoen, S; Hoepelman, AI; van Erpecum, KJ | 1 |
Barreiro, P; Chagas, C; Magalhães-Costa, P; Matos, L | 1 |
Fordyce, MW; Hitchcock, MJ; Ray, AS | 1 |
Gosset, C; Molina, JM; Penot, P; Verine, J | 1 |
Beraud, G; Chagneau-Derrode, C; Garcia, M; Godet, C; Le Moal, G; Roblot, F | 1 |
Jung, YK; Kang, K; Kim, D; Kim, DH; Lee, J; Suh, SJ; Yim, HJ | 1 |
Flamant, M; Joseph, A; Vidal-Petiot, E; Yazdanpanah, Y | 1 |
Balboa, P; Galaz, MI; Galindo, A; Romero, P; Torrejón, C; Vivanco, M; Zúñiga, M | 1 |
Chatelut, E; Jaafar, A; Malard, L; Massip, P; Séronie-Vivien, S; Tack, I | 1 |
Albalater, M; Barreiro, P; Blanco, F; Labarga, P; Martin-Carbonero, L; Medrano, J; Moreno, V; Rivas, P; Rodriguez-Novoa, S; Solera, C; Soriano, V; Vispo, E | 1 |
Aslangul, E; Caillat-Vigneron, N; Le Jeunne, C; Perrot, S; Szwebel, T | 1 |
Alvarez, S; Brumble, LM; Dwyer, JP; Irizarry-Alvarado, JM; Mendez, JC | 1 |
Atta, MG; Fine, DM | 1 |
Connolly, JO; Copas, A; Edwards, SG; Hall, AM; Johnson, MA; Madge, S; Nair, D; Williams, IG; Woodward, CL | 1 |
Cosyns, JP; Jadoul, M; Jouret, F; Labriola, L; Lambert, M; Morelle, J | 1 |
Bersoff-Matcha, S; Blank, J; Chang, J; Horberg, M; Hurley, L; Klein, D; Quesenberry, C; Silverberg, M; Tang, B; Towner, W | 1 |
Dinsmore, WW; Donnelly, CM; Emerson, CR; Quinn, KJ | 1 |
Mir, M; Rodríguez, B; Sanz, J; Vilchez-Aparicio, V | 1 |
Benhamou, Y; Izzedine, H; Peytavin, G; Schneider, L; Thibault, V; Valantin, MA | 1 |
Aba, YT; Aoussi, EF; Bissagnene, E; Eholié, SP; Ehui, E; Kadio, A; Kakou, AR; Kassi, A; Ondounda, M; Ouattara, I; Tanon, A | 1 |
León, E; Lozano de León-Naranjo, F; Pérez-Rivera, AÁ; Sáez, P | 1 |
Kuijper, A; Mudrikova, T; Rookmaker, MB | 1 |
Connolly, JO; Hall, AM; Hendry, BM; Nitsch, D | 1 |
Bonnet, F; Cazanave, C; Dabis, F; Dauchy, FA; de La Faille, R; Dupon, M; Greib, C; Lawson-Ayayi, S; Mehsen, N; Miremont-Salamé, G; Rigothier, C | 1 |
Bronsveld, W; Haverkort, ME; Huitema, AD; Lips, P; Slieker, WA; ter Heine, R; van der Spek, BW | 1 |
Lane, JM; Rebolledo, BJ; Unnanuntana, A | 1 |
Hitomi, S; Kiyasu, Y; Koganemaru, H | 1 |
Fernando, M; Gracey, DM; Post, JJ; White, CP; Ziegler, J | 1 |
Casado, JL; del Palacio, M; Romero, S | 1 |
Fouqueray, B; Girard, PM; Meynard, JL; Monge, M; Mougenot, B; Ronco, P; Rossert, J; Verhelst, D | 1 |
Créput, C; Gonzalez-Canali, G; Hill, G; Kazatchkine, M; Nochy, D; Piketty, C | 1 |
Bourgarit, A; Droz, D; Furco, A; Karras, A; Lafaurie, M; Legendre, C; Martinez, F; Molina, JM; Sereni, D | 1 |
Callens, S; Colebunders, R; De Roo, A | 1 |
Abad, S; Blanche, P; Chauvelot-Moachon, L; Daniel, N; Kélaïdi, C; Nazal, EM; Rollot, F; Saba, M | 1 |
Dressier, RM; James, CW; Steinhaus, MC; Szabo, S | 1 |
Earle, KE; Seneviratne, T; Shaker, J; Shoback, D | 1 |
de Guzmán, M; García-Reyne, A; Gaspar, G; Monereo, A | 1 |
Allen, PC; Bendele, R; Bennett, DR; Bischofberger, N; Brignolo, LL; Canfield, DR; Castillo, AB; Dearman, TG; Desjardins, J; Hamilton, M; Hirst, LL; Jerome, C; Marthas, ML; Martin, RB; Meyer, DJ; Pedersen, NC; Samii, VF; Spinner, A; Tarara, R; Valverde, C; Van Rompay, KK; Von Morgenland, W | 1 |
Alexandre, M; Breton, G; Duval, X; Leport, C; Peytavin, G; Prie, D; Vildei, JL | 1 |
Perazella, MA; Rifkin, BS | 1 |
Bannister, A; Day, SL; Fisher, M; Hankins, M; Leake Date, HA | 1 |
Bignani, O; Delfraissy, JF; Goujard, C; Harmouche, H; Le Bras, P | 1 |
Abraham, P; Malik, A; Malik, N | 1 |
Fine, DM | 2 |
Brito, MO; Quimby, D | 1 |
Chadwick, DR; Williams, J | 1 |
Issa, BG; Parsonage, MJ; Savage, MW; Snowden, N; Wilkins, EG | 1 |
Hussain, S; Khayat, A; Rathore, MH; Tolaymat, A | 1 |
Shepp, DH; Winston, J | 1 |
Knaus, SJ; Mathew, G | 1 |
Haas, DW; Hulgan, T | 1 |
Deray, AG; Dominguez, S; Ghosn, J; Goyenvalle, C; Hulot, JS; Izzedine, H; Lechat, P; Valantin, MA; Villard, E | 1 |
de la Prada, FJ; Morey, A; Prados, AM; Saus, C; Tugores, A; Uriol, M | 1 |
Curtis, S; Rooney, JF; Shepp, DH | 1 |
Brim, NM; Cu-Uvin, S; Hu, SL; O'Bell, JW | 1 |
Gupta, SK | 1 |
9 review(s) available for tenofovir and Adult Fanconi Syndrome
Article | Year |
---|---|
Fanconi syndrome induced by the long-term use of tenofovir disoproxil fumarate: a case report and literature review.
Topics: Fanconi Syndrome; Female; Hepatitis B; Humans; Pain; Tenofovir; Tomography, X-Ray Computed | 2023 |
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.
Topics: Adenine; Alanine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Drug Stability; Fanconi Syndrome; HIV Infections; HIV-1; Humans; Kidney; Prodrugs; Tenofovir; Virus Replication | 2016 |
Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.
Topics: Adenine; Animals; Fanconi Syndrome; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Organophosphonates; Risk Factors; Tenofovir | 2011 |
The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; Organophosphonates; Retinol-Binding Proteins; Reverse Transcriptase Inhibitors; Tenofovir | 2012 |
Tenofovir-related nephrotoxicity: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Clinical Chemistry Tests; Fanconi Syndrome; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome | 2004 |
Fanconi's syndrome in HIV+ adults: report of three cases and literature review.
Topics: Adenine; Adult; Anti-Retroviral Agents; Bone Density; Calcitriol; Calcium; Fanconi Syndrome; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Phosphates; Tenofovir | 2004 |
Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Humans; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2005 |
Editorial comment: tenofovir nephrotoxicity--vigilance required.
Topics: Adenine; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Organophosphonates; Proteinuria; Renal Insufficiency; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature.
Topics: Adenine; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
83 other study(ies) available for tenofovir and Adult Fanconi Syndrome
Article | Year |
---|---|
Fanconi syndrome in a patient receiving pre-exposure prophylaxis for HIV infection: case report.
Topics: Anti-HIV Agents; Emtricitabine; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Proteinuria; Renal Insufficiency; Tenofovir | 2022 |
Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Fanconi Syndrome; Female; HIV Infections; Humans; Kenya; Male; Phosphates; Tenofovir | 2022 |
Topics: Drug-Related Side Effects and Adverse Reactions; Fanconi Syndrome; Humans; Tenofovir | 2023 |
Fanconi syndrome, diabetes insipidus, and acute kidney injury due to tenofovir disoproxil fumarate: A case report.
Topics: Acute Kidney Injury; Adenine; Anti-HIV Agents; Diabetes Insipidus; Diabetes Mellitus; Fanconi Syndrome; Female; HIV Infections; Humans; Middle Aged; Protease Inhibitors; Tenofovir | 2023 |
Severe skeletal damage suggesting neoplastic disease as a manifestation of tenofovir-induced Fanconi syndrome in chronic hepatitis B.
Topics: Antiviral Agents; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Neoplasms; Tenofovir | 2023 |
Life-threatening rhabdomyolysis and Fanconi syndrome related to tenofovir disoproxil fumarate administration in an HIV-infected patient.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Drug Therapy, Combination; Fanconi Syndrome; Fluid Therapy; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Rhabdomyolysis; Tenofovir | 2020 |
Fanconi Syndrome and Tenofovir Alafenamide.
Topics: Adenine; Alanine; Anti-HIV Agents; Fanconi Syndrome; Humans; Tenofovir | 2019 |
Fanconi Syndrome and Tenofovir Alafenamide.
Topics: Adenine; Alanine; Anti-HIV Agents; Fanconi Syndrome; Humans; Tenofovir | 2019 |
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hypophosphatemia; Organophosphonates; Osteomalacia; Tenofovir | 2020 |
Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
Topics: Adolescent; Anti-HIV Agents; Child; Cross-Sectional Studies; Fanconi Syndrome; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Tertiary Care Centers; Zimbabwe | 2020 |
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
Topics: Acute Disease; Alanine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemotherapy-Induced Febrile Neutropenia; Deprescriptions; Drug Interactions; Fanconi Syndrome; Gentamicins; Glycosuria; HIV Infections; Hodgkin Disease; Humans; Hypokalemia; Hypophosphatemia; Male; Middle Aged; Proteinuria; Tenofovir | 2020 |
Tenofovir-induced delayed nephro-osteo toxicity.
Topics: Child; Fanconi Syndrome; HIV Infections; Humans; Incidence; Male; Middle Aged; Osteomalacia; Tenofovir | 2020 |
Tenofovir-induced osteomalacia with hypophosphataemia.
Topics: Antiviral Agents; Fanconi Syndrome; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Osteomalacia; Tenofovir | 2021 |
Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient.
Topics: Adenine; Alanine; Anti-HIV Agents; Coinfection; Fanconi Syndrome; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Tenofovir; Treatment Outcome | 2017 |
Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate.
Topics: Adult; Anti-HIV Agents; Australia; Creatinine; Fanconi Syndrome; HIV Infections; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tenofovir | 2018 |
Pathologic femoral fracture due to tenofovir-induced Fanconi syndrome in patient with chronic hepatitis B: A case report.
Topics: Antiviral Agents; Fanconi Syndrome; Femoral Fractures; Fractures, Spontaneous; Hepatitis B, Chronic; Humans; Male; Middle Aged; Tenofovir | 2017 |
Concomitant AIDS cholangiopathy and Fanconi syndrome as complications of HIV in a single patient.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cholangitis; Fanconi Syndrome; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Tenofovir; Zidovudine | 2017 |
Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.
Topics: Antiviral Agents; Bone Density Conservation Agents; Denosumab; Fanconi Syndrome; Fractures, Stress; Hepatitis B, Chronic; Humans; Hypophosphatemia; Male; Middle Aged; Osteomalacia; Radiography; Radionuclide Imaging; Tenofovir; Tibial Fractures; Tomography, X-Ray Computed | 2019 |
Fanconi Syndrome and Tenofovir Alafenamide: A Case Report.
Topics: Adenine; Alanine; Antiviral Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Tenofovir | 2019 |
[Marked improvement in renal tubular markers after switching from adefovir to tenofovir alafenamide in a case of Fanconi syndrome diagnosed through high ALP levels].
Topics: Adenine; Alanine; Alkaline Phosphatase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Fanconi Syndrome; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Middle Aged; Organophosphonates; Tenofovir; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
A case of entecavir-induced Fanconi syndrome.
Topics: Acidosis; Acute Kidney Injury; Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Guanine; Hepatitis B, Chronic; Humans; Hypokalemia; Hypophosphatemia; Male; Nucleosides; Tenofovir; Treatment Outcome; Withholding Treatment | 2019 |
Fanconi syndrome due to tenofovir disoproxil fumarate (TDF) after liver transplantation.
Topics: Antiviral Agents; Fanconi Syndrome; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Tenofovir; Transplant Recipients | 2019 |
Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection.
Topics: Adenine; Adult; Antiviral Agents; Biopsy; Creatinine; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Kidney; Male; Middle Aged; Organophosphonates; Phosphates; Reverse Transcriptase Inhibitors; Tenofovir | 2013 |
Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.
Topics: Adenine; Adolescent; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Organophosphonates; Osteomalacia; Tenofovir | 2013 |
Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Interactions; Fanconi Syndrome; Female; Germany; HIV Infections; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir | 2013 |
Interactive medical case: wasting away.
Topics: Adenine; Adult; Bone Density; Electrolytes; Fanconi Syndrome; Female; Hepatitis B, Chronic; Humans; Hypokalemia; Nausea; Organophosphonates; Osteomalacia; Pain; Reverse Transcriptase Inhibitors; Tenofovir | 2014 |
Clinical problem-solving. Wasting away.
Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir | 2014 |
Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Topics: Adenine; Animals; Anti-HIV Agents; Electron Transport Chain Complex Proteins; Fanconi Syndrome; Kidney Tubules, Proximal; Male; Mitochondria; Mitochondrial Swelling; Organophosphonates; Proteinuria; Rats, Wistar; Tenofovir | 2014 |
Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
Topics: Adenine; Adult; Anti-HIV Agents; Case-Control Studies; Creatinine; Fanconi Syndrome; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Prognosis; Prospective Studies; Risk Factors; Tenofovir | 2014 |
Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.
Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Fanconi Syndrome; Fibroblast Growth Factor-23; Fibroblast Growth Factors; HIV Infections; Humans; Hypophosphatemia; Male; Organophosphonates; Osteomalacia; Osteoporosis; Tenofovir | 2014 |
Tenofovir-associated Fanconi syndrome in a patient with chronic hepatitis B.
Topics: Adenine; Aged, 80 and over; Antiviral Agents; Fanconi Syndrome; Fatal Outcome; Hepatitis B, Chronic; Humans; Male; Organophosphonates; Risk Factors; Tenofovir | 2014 |
Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.
Topics: Adenine; Antiviral Agents; Fanconi Syndrome; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Outcome; Viral Load; Withholding Treatment | 2014 |
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.
Topics: Adenine; Alleles; Anti-HIV Agents; Biomarkers, Pharmacological; Case-Control Studies; Fanconi Syndrome; Genetic Association Studies; HEK293 Cells; HIV Infections; HIV-1; Humans; Multidrug Resistance-Associated Protein 2; Organophosphonates; Pharmacogenetics; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Tenofovir | 2015 |
Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection.
Topics: Adult; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis B, Chronic; Humans; Nephrotic Syndrome; Tenofovir | 2015 |
Renal proximal tubular dysfunction due to tenofovir in a patient with chronic hepatitis B monoinfection.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Immunocompromised Host; Male; Middle Aged; Phosphates; Tenofovir; Treatment Outcome | 2015 |
Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir.
Topics: Adult; Antiviral Agents; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Kidney Failure, Chronic; Male; Tenofovir | 2015 |
Tenofovir disoproxil fumarate-induced Fanconi's syndrome during HIV postexposure prophylaxis.
Topics: Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Post-Exposure Prophylaxis; Sexual Behavior; Tenofovir; Treatment Outcome; Unsafe Sex | 2016 |
First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
Topics: Absorptiometry, Photon; Adenine; Alanine; Coinfection; Dose-Response Relationship, Drug; Fanconi Syndrome; Hepatitis B, Chronic; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Outcome | 2016 |
[A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B].
Topics: Antiviral Agents; Bone and Bones; Calcifediol; Fanconi Syndrome; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Male; Middle Aged; Osteomalacia; Phosphates; Renal Reabsorption; Tenofovir | 2016 |
[Tenofovir-induced Fanconi syndrome and recovery after treatment cessation: A case report with physiological considerations].
Topics: Adult; Anti-HIV Agents; Fanconi Syndrome; Female; HIV Infections; Humans; Remission Induction; Tenofovir; Withholding Treatment | 2017 |
[Tenofovir-associated Fanconi`s syndrome and rickets in a HIV infected girl].
Topics: Anti-HIV Agents; Child; Fanconi Syndrome; Female; HIV Infections; Humans; Rickets; Tenofovir | 2017 |
Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
Topics: Adenine; Anti-HIV Agents; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; HIV Infections; Humans; Hypophosphatemia; Organophosphonates; Retrospective Studies; Sensitivity and Specificity; Tenofovir | 2009 |
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatinine; Epidemiologic Methods; Fanconi Syndrome; Female; HIV Infections; Humans; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |
Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Topics: Adenine; Bone Density Conservation Agents; Fanconi Syndrome; Female; Fractures, Bone; HIV Infections; Humans; Middle Aged; Organophosphonates; Osteomalacia; Pain; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |
Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Topics: Adenine; Adult; Anti-HIV Agents; Diabetes Insipidus; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |
Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
Topics: Adenine; Anti-HIV Agents; Clinical Trials as Topic; Diabetes Insipidus; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; HIV Infections; Humans; Kidney Function Tests; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir | 2009 |
Tenofovir-associated renal and bone toxicity.
Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Glycosuria; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Mass Screening; Middle Aged; Organophosphonates; Osteomalacia; Proteinuria; Radionuclide Imaging; Tenofovir | 2009 |
Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction.
Topics: Acute Kidney Injury; Adenine; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Diagnosis, Differential; Diclofenac; Drug Synergism; Drug Therapy, Combination; Fanconi Syndrome; Female; HIV Antibodies; HIV Seropositivity; HIV-1; Humans; Kidney Tubules, Proximal; Middle Aged; Organophosphonates; Tenofovir | 2009 |
Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.
Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Creatinine; Fanconi Syndrome; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Function Tests; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Retrospective Studies; Tenofovir | 2010 |
Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Incidence; Organophosphonates; Retrospective Studies; Tenofovir; United Kingdom | 2010 |
[Fanconi syndrome associated with tenofovir treatment: a presentation of two cases].
Topics: Adenine; Adult; Fanconi Syndrome; Humans; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?
Topics: Adenine; Fanconi Syndrome; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Probenecid; Secondary Prevention; Tenofovir | 2010 |
[Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast].
Topics: Adenine; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cote d'Ivoire; Cyclopropanes; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Fanconi Syndrome; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Malaria; Male; Middle Aged; Organophosphonates; Pyelonephritis; Pyrimidinones; Ritonavir; Tenofovir | 2011 |
[HIV infected women with intense bone and muscular pain and general weakness].
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Fanconi Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Muscle Weakness; Musculoskeletal Diseases; Organophosphonates; Osteomalacia; Pain; Radionuclide Imaging; Radiopharmaceuticals; Substance Abuse, Intravenous; Technetium Tc 99m Medronate; Tenofovir | 2011 |
[Renal adverse reactions of antiretroviral medication: proximal tubular dysfunction associated with tenofovir].
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Tenofovir | 2011 |
Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
Topics: Adenine; Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cross-Sectional Studies; Fanconi Syndrome; Female; France; HIV Infections; HIV-1; Humans; Kidney Tubules, Proximal; Logistic Models; Male; Middle Aged; Odds Ratio; Oligopeptides; Organophosphonates; Prevalence; Pyridines; Risk Assessment; Risk Factors; Tenofovir; Time Factors | 2011 |
Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.
Topics: Adenine; Adult; Anti-HIV Agents; Diphosphates; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Osteomalacia; Radionuclide Imaging; Tenofovir; Whole Body Imaging | 2011 |
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidity; Fanconi Syndrome; Female; Femoral Neck Fractures; Fractures, Spontaneous; Hip Fractures; HIV Infections; Humans; Magnetic Resonance Imaging; Middle Aged; Organophosphonates; Osteoporotic Fractures; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure | 2011 |
Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Fanconi Syndrome; Female; HIV Infections; HIV-1; Humans; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2012 |
An unrecognised case of tenofovir-associated Fanconi syndrome.
Topics: Adenine; Adolescent; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Organophosphonates; Tenofovir | 2012 |
Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; Female; HIV Seropositivity; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2002 |
Renal lesions in HIV-1-positive patient treated with tenofovir.
Topics: Acute Kidney Injury; Adenine; Anti-HIV Agents; Fanconi Syndrome; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2003 |
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Topics: Acidosis; Adenine; Adult; Anti-HIV Agents; Creatinine; Diabetes Insipidus, Nephrogenic; Drug Monitoring; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Renal Insufficiency; Tenofovir | 2003 |
Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fanconi Syndrome; Female; HIV Seropositivity; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Rhabdomyolysis; Tenofovir | 2003 |
Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Humans; Lopinavir; Male; Organophosphonates; Organophosphorus Compounds; Pyrimidinones; Ritonavir; Tenofovir | 2003 |
Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; HIV Seropositivity; HIV-1; Humans; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2004 |
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.
Topics: Absorptiometry, Photon; Adenine; Animals; Animals, Newborn; Anti-HIV Agents; Area Under Curve; Blood Chemical Analysis; Bone and Bones; Bone Density; Dose-Response Relationship, Drug; Fanconi Syndrome; Female; Glycosuria; Half-Life; Macaca mulatta; Male; Organophosphonates; Organophosphorus Compounds; Phosphorus; Tenofovir; Time Factors; Weight Gain | 2004 |
Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Topics: Adenine; Anti-HIV Agents; Drug Therapy, Combination; Fanconi Syndrome; HIV Infections; HIV-1; Humans; Hypophosphatemia; Kidney Tubules; Organophosphonates; Organophosphorus Compounds; Polyuria; Reverse Transcriptase Inhibitors; Tenofovir | 2004 |
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2004 |
Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Chemical Analysis; Creatinine; Fanconi Syndrome; Female; HIV Infections; Humans; Hypophosphatemia; Lopinavir; Male; Organophosphonates; Phosphates; Prospective Studies; Pyrimidinones; Reproducibility of Results; Tenofovir; Urea | 2005 |
[Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir].
Topics: Acute Kidney Injury; Adenine; Adult; Diabetes Insipidus; Fanconi Syndrome; HIV Infections; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2005 |
Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.
Topics: Adenine; Anti-HIV Agents; Bone Density Conservation Agents; Fanconi Syndrome; HIV Infections; Humans; Hydroxycholecalciferols; Hypocalcemia; Male; Middle Aged; Organophosphonates; Phosphates; Tenofovir; Treatment Outcome | 2006 |
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fanconi Syndrome; Female; HIV Infections; Humans; Hypophosphatemia; Male; Middle Aged; Muscular Diseases; Organophosphonates; Osteomalacia; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
Topics: Adenine; Anti-HIV Agents; Child; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Lopinavir; Organophosphonates; Pregnancy; Pregnancy Complications; Pyrimidinones; Ritonavir; Tenofovir | 2006 |
Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.
Topics: Adenine; Creatinine; Dose-Response Relationship, Drug; Fanconi Syndrome; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Osteomalacia; Reverse Transcriptase Inhibitors; Tenofovir | 2006 |
Acquired Fanconi's syndrome associated with tenofovir therapy.
Topics: Adenine; Adult; Fanconi Syndrome; Humans; Male; Organophosphonates; Tenofovir | 2006 |
Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; Haplotypes; HIV Infections; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Pharmacogenetics; Polymorphism, Single Nucleotide; Tenofovir | 2006 |
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Case-Control Studies; Fanconi Syndrome; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; HIV Infections; Humans; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Point Mutation; Polymorphism, Single Nucleotide; Statistics as Topic; Tenofovir | 2006 |
[Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Aged; Anti-HIV Agents; Fanconi Syndrome; Female; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2006 |
Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.
Topics: Adenine; Adult; Cause of Death; Drug Monitoring; Drug Synergism; Fanconi Syndrome; Female; Guideline Adherence; HIV Infections; HIV-1; Humans; Hypokalemia; Male; Middle Aged; Organophosphonates; Product Surveillance, Postmarketing; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |
Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Fanconi Syndrome; Female; Femoral Neck Fractures; HIV Infections; Humans; Middle Aged; Organophosphonates; Tenofovir | 2007 |
Editorial comment: Fanconi syndrome and tenofovir--understanding proximal tubular function.
Topics: Adenine; Adult; Anti-HIV Agents; Child; Fanconi Syndrome; Humans; Kidney Tubules, Proximal; Organophosphonates; Tenofovir | 2007 |
Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.
Topics: Adenine; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-HIV Agents; Child; Fanconi Syndrome; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Organophosphonates; Registries; Retrospective Studies; Risk Assessment; Survival Analysis; Tenofovir; United States; United States Food and Drug Administration | 2008 |